JAGSNPHARM
JAGSONPAL PHARMACEUTICALS

169.07 +0.25 (+0.15%)

JAGSNPHARM investors incur serious losses

01 Feb, 20265 min read

JAGSNPHARM delivered massive losses today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.1% per day. Sunday's performance of +0.15% was a outperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}